Trinoxteride convenes doctors to break stigma on women’s hair loss
Text size
Share
Daily TribuneShare
Doctors, experts, and advocates unite in a groundbreaking dialogue on female hair loss and the debut of Redensyl®-powered innovations.
Photo by Jefferson Fernando for DAILY TRIBUNE
Panelists agreed that Redensyl® bridges a critical gap in dermatological care — combining science, safety, and inclusivity for a demographic that has long felt underserved in the hair care industry.
Jefferson Fernando
In a bid to address one of the most overlooked health and beauty concerns among Filipinas, Trinoxteride convened a panel of 13 doctors and medical experts for a landmark roundtable discussion at The Vault in Bonifacio Global City to talk about women’s hair loss — a condition often suffered in silence.
While conversations about male pattern baldness have become more accepted, many women continue to struggle with hair thinning, shedding, and alopecia without seeking help due to stigma. The forum aimed to break that silence and foster medically guided awareness and empathy.
The discussion featured experts including Dr. Lyien Ho, Dr. Kat Pastrana, Dr. Kerima Danica Gayo, Dr. Alexanderine Go, Dr. Cel Martinez, Dr. Jaea Acosta, Dr. Toby Cruz, Dr. Faith Racho, Dr. Erick Merioles, Dr. Neil Isaguire, Dr. Via Izobela, Dr. Alexandra Portillo, and Dr. Shine Reyes. They emphasized how societal pressure prevents many women from addressing hair loss early.
“Hair is deeply tied to confidence, identity, and self-worth,” one physician noted. “When women experience hair loss, it’s not just a cosmetic concern—it becomes a psychological one. That’s why awareness and early intervention are essential.”
The event also marked the soft launch of Trinoxteride’s Redensyl®-Powered Hair Loss Preventive System, a three-step regimen designed to help prevent early-stage hair fall in men, women, and children. Redensyl®, a plant-derived compound, is being recognized globally as a gentler, non-hormonal alternative to conventional treatments.
CEO Ramon Natcher said the brand’s mission is to provide “safe, science-backed solutions for the Filipino market.”
“Redensyl® offers the efficacy of conventional treatments while remaining gentle, non-hormonal, and suitable for broader use,” Natcher explained. “Our goal is to make preventive hair care accessible, effective, and rooted in scientific integrity.”
During the medical review segment, physicians affirmed Redensyl®’s clinical potential for stimulating hair growth and reducing hair fall, particularly among women hesitant to pursue aggressive treatment options.
Adding a personal dimension to the event, Miss Universe Baguio 2025 Gwendoline Meliz Soriano shared her journey with alopecia areata and the emotional toll it took during her pageant preparation.
“When I started losing my hair, I thought I was losing my crown,” she said. “But I realized that healing begins when we stop hiding. Hair loss doesn’t make us less beautiful; it makes us human.”
The event underscored a broader call to reframe women’s hair loss as both a medical and emotional wellness issue — one best addressed through awareness, empathy, and science-backed solutions.
